Allergen labeling guidance
This article was originally published in The Tan Sheet
Executive Summary
"Is a major food allergen that has been unintentionally added to a food as a result of cross-contact subject to FALCPA's labeling requirements?" is a question FDA answers in the second edition of its industry guidance on the Food Allergen Labeling & Consumer Protection Act of 2004. According to the document, major food allergens that are "unintentionally" added to a food due to cross-contact are not subject to FALCPA labeling requirements. The agency first released the question-and-answer guidance in October and expects to issue new editions as more questions are posed by industry (1"The Tan Sheet" Oct. 24, 2005, p. 10). The deadline for FALCPA labeling compliance is Jan. 1...
You may also be interested in...
FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens
Manufacturers of dietary supplements are required to begin labeling products that contain major food allergens on Jan. 1 in order to comply with the Food Allergen Labeling & Consumer Protection Act of 2004 (FALCPA)
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: